OMERS ADMINISTRATION Corp Trims Holdings in Danaher Corporation $DHR

OMERS ADMINISTRATION Corp decreased its stake in shares of Danaher Corporation (NYSE:DHR) by 5.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 82,167 shares of the conglomerate’s stock after selling 4,608 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Danaher were worth $18,810,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. JPL Wealth Management LLC purchased a new position in Danaher during the third quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth approximately $26,000. WFA of San Diego LLC purchased a new position in Danaher during the second quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the third quarter worth approximately $27,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter worth approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR stock opened at $181.04 on Tuesday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The stock has a market cap of $128.13 billion, a price-to-earnings ratio of 35.02, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The business has a fifty day moving average of $180.73 and a two-hundred day moving average of $204.27.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.88 EPS. As a group, research analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on DHR shares. Rothschild & Co Redburn set a $205.00 target price on Danaher in a research note on Friday, April 17th. JPMorgan Chase & Co. cut their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Barclays cut their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Finally, TD Cowen cut their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.